Skip to Content
Merck
  • Characteristic epithelium with low-grade atypia appears on the surface of gastric cancer after successful Helicobacter pylori eradication therapy.

Characteristic epithelium with low-grade atypia appears on the surface of gastric cancer after successful Helicobacter pylori eradication therapy.

Helicobacter (2014-04-29)
Yoko Kitamura, Masanori Ito, Taiji Matsuo, Tomoyuki Boda, Shiro Oka, Masaharu Yoshihara, Shinji Tanaka, Kazuaki Chayama
ABSTRACT

The incidence of gastric cancer after successful Helicobacter pylori eradication has been increasing. We previously reported that epithelium with low-grade atypia (ELA) appeared on the surface of gastric cancer after H. pylori eradication. Here, we investigate the clinical and biological characteristics of such ELA. We studied 27 cases of gastric cancer detected after successful H. pylori eradication therapy. We examined the prevalence of ELA among these cases and its significance for endoscopic discovery after H. pylori eradication. We additionally investigated the mucus, p53 and Ki67 expressions in ELA. Epithelium with low-grade atypia that continuous with the gastric tumor was detected in 22 of 27 cases (81%), a significantly greater percentage than that for controls (p < 0.01). We found that gastric-type mucin was frequently expressed in this epithelium. Neither p53- nor Ki67-positive cells were found in ELA, irrespective of their expression in tumor tissue. The presence of ELA was positively correlated with the clinical interval between H. pylori eradication and gastric cancer detection. Epithelium with low-grade atypia on gastric cancer tissue, which may develop from gastric cancer cells, is frequently present after successful eradication therapy. This phenomenon could influence the practice of endoscopic diagnosis of gastric cancers.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Urea solution, 40 % (w/v) in H2O
Sigma-Aldrich
Urea solution, BioUltra, ~8 M in H2O
Sigma-Aldrich
Urea-12C, 99.9 atom % 12C
Millipore
Urea solution, suitable for microbiology, 40% in H2O
Urea, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Anti-TP53 (ab3) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Urea, ≥99.0%
Sigma-Aldrich
Urea, SAJ first grade, ≥98.0%
Sigma-Aldrich
Anti-CDX2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Urea, BioUltra, for molecular biology, 99% (T)
Sigma-Aldrich
Urea, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%
Sigma-Aldrich
Urea, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%, 99.0-101.0% (calc. on dry substance)
Sigma-Aldrich
Urea, ReagentPlus®, ≥99.5%, pellets
Sigma-Aldrich
Urea, meets USP testing specifications
Sigma-Aldrich
Urea, BioXtra, pH 7.5-9.5 (20 °C, 5 M in H2O)
Sigma-Aldrich
Urea, suitable for electrophoresis
Sigma-Aldrich
Urea, ACS reagent, 99.0-100.5%
Supelco
Urea, analytical standard
Sigma-Aldrich
Urea, JIS special grade, ≥99.0%
Sigma-Aldrich
Urea, powder, BioReagent, for molecular biology, suitable for cell culture
USP
Urea, United States Pharmacopeia (USP) Reference Standard
Supelco
Urea, 8 M (after reconstitution with 16 mL high purity water)